BibTex Citation Data :
@article{JMKI51460, author = {Nufika Fatasyadhuha and Sutopo Jati and Nurhasmadiar Nandini}, title = {Evaluasi Prolanis Hipertensi Berbasis Teori Chain of Events di Puskesmas Playen II}, journal = {Jurnal Manajemen Kesehatan Indonesia}, volume = {11}, number = {2}, year = {2023}, keywords = {Evaluation, Prolanis, Hypertension, Chain of Events}, abstract = { According to the 2018 Riskesdas data, hypertension is a non-communicable disease with a significant increase in trend. Considering this case, hypertension has an urgency to be treated because it is a risk factor for the highest cause of death and disability according to the Institute for Health Metrics and Evaluation 2019. In this case Prolanis can be used as an alternative treatment for hypertension because it meets the criteria for the benefits of non-pharmacological therapy. We chose Puskesmas Playen II in Gunungkidul Regency as our research site because the coverage of providing hypertension services through Prolanis is still low, considering from the secondary data from the Gunungkidul Regency Health Office in 2020 where the percentage of hypertension services at the Puskesmas Playen II was only 0.3%, far below the 29 other puskesmas in Gunungkidul Regency. Hence, the study aimed to evaluate Prolanis' achievements in hypertension in Puskesmas Playen II using the Chain of Events evaluation theory. This research is qualitative with an evaluation study design. There were 15 informants as research subjects selected by purposive sampling. Prolanis' achievements in hypertension at Puskesmas Playen II have not reached the minimum target of 5% based on BPJS Kesehatan Regulation Number 7 of 2019, because the number of Prolanis-registered hypertensive patients is increasing but not matched with the increasing number of controlled hypertension sufferers. The Prolanis component also influences its unattainable achievement in follow-up treatment, so it is necessary to conduct routine monitoring of Prolanis participants’ lifestyles. }, issn = {2548-7213}, pages = {119--131} doi = {10.14710/jmki.11.2.2023.119-131}, url = {https://ejournal.undip.ac.id/index.php/jmki/article/view/51460} }
Refworks Citation Data :
According to the 2018 Riskesdas data, hypertension is a non-communicable disease with a significant increase in trend. Considering this case, hypertension has an urgency to be treated because it is a risk factor for the highest cause of death and disability according to the Institute for Health Metrics and Evaluation 2019. In this case Prolanis can be used as an alternative treatment for hypertension because it meets the criteria for the benefits of non-pharmacological therapy. We chose Puskesmas Playen II in Gunungkidul Regency as our research site because the coverage of providing hypertension services through Prolanis is still low, considering from the secondary data from the Gunungkidul Regency Health Office in 2020 where the percentage of hypertension services at the Puskesmas Playen II was only 0.3%, far below the 29 other puskesmas in Gunungkidul Regency. Hence, the study aimed to evaluate Prolanis' achievements in hypertension in Puskesmas Playen II using the Chain of Events evaluation theory. This research is qualitative with an evaluation study design. There were 15 informants as research subjects selected by purposive sampling. Prolanis' achievements in hypertension at Puskesmas Playen II have not reached the minimum target of 5% based on BPJS Kesehatan Regulation Number 7 of 2019, because the number of Prolanis-registered hypertensive patients is increasing but not matched with the increasing number of controlled hypertension sufferers. The Prolanis component also influences its unattainable achievement in follow-up treatment, so it is necessary to conduct routine monitoring of Prolanis participants’ lifestyles.
Article Metrics:
Last update:
Last update: 2024-10-07 13:45:34
The Authors submitting a manuscript do so on the understanding that if accepted for publication, copyright of the article shall be assigned to JMKI journal and Master’s Study Program in Public Health, Faculty of Public Health, Diponegoro University as the publisher of the journal. Copyright encompasses rights to reproduce and deliver the article in all form and media, including reprints, photographs, microfilms, and any other similar reproductions, as well as translations.
JMKI journal and Master of Public Health Study Program, Universitas Diponegoro and the Editors make every effort to ensure that no wrong or misleading data, opinions or statements be published in the journal. In any way, the contents of the articles and advertisements published in JMKI journal are the sole and exclusive responsibility of their respective authors and advertisers.
The Copyright Transfer Form can be downloaded here: [Copyright Transfer Form JMKI]. The copyright form should be signed originally and send to the Editorial Office in the form of original mail, scanned document or fax :
Farid Agushybana, S.KM., Ph.D (Editor-in-Chief)Editorial Office of Jurnal Manajemen Kesehatan IndonesiaMaster of Public Health Study Program, Universitas DiponegoroJl. Prof. Soedarto, Kampus Undip Tembalang, Semarang, Central Java, Indonesia 50275Telp./Fax: +62-24-7460044Email: hybana@gmail.com / jmki@live.undip.ac.id
Jurnal Manajemen Kesehatan Indonesia (e-ISSN: 2548-7213, p-ISSN: 2303-3622) is published by Master of Publich Health, Faculty of Public Health, Universitas Diponegoro under a Creative Commons Attribution 4.0 International License.
View statistics